Foghorn Therapeutics Inc (FHTX) — Financial Flexibility Index
Foghorn Therapeutics Inc (FHTX) has a Financial Flexibility Index of -0.07x as of December 2025. Free cash flow of $-22.27 Million (operating CF $-22.27 Million minus capex $0.00) represents 0% of total liabilities ($306.60 Million). Check FHTX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Foghorn Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Foghorn Therapeutics Inc across 8 annual periods. See FHTX working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Foghorn Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Foghorn Therapeutics Inc. For the full company profile including market capitalisation, see Foghorn Therapeutics Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.28x | $-86.05 Million | $-86.10 Million | $306.60 Million | ▲ +7.1% |
| 2024 | -0.30x | $-99.50 Million | $-100.41 Million | $329.51 Million | ▲ +6.2% |
| 2023 | -0.32x | $-116.88 Million | $-118.11 Million | $363.11 Million | ▼ -166.9% |
| 2022 | 0.48x | $194.82 Million | $193.61 Million | $404.77 Million | ▲ +533.7% |
| 2021 | -0.11x | $-46.94 Million | $-50.25 Million | $422.90 Million | ▲ +19.6% |
| 2020 | -0.14x | $-15.10 Million | $-31.29 Million | $109.41 Million | ▲ +66.4% |
| 2019 | -0.41x | $-45.37 Million | $-46.34 Million | $110.36 Million | ▼ -60.4% |
| 2018 | -0.26x | $-21.11 Million | $-22.65 Million | $82.33 Million | — |